Effective OnabotulinumtoxinA Dose Response Study for Upper Facial Wrinkles

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 25, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

May 30, 2025

Conditions
Rhytides
Interventions
DRUG

OnabotulinumtoxinA Standard Dose

Active comparator group will be treated for full upper face wrinkles with standard recommended doing of onabotulinumtoxinA

DRUG

OnabotulinumtoxinA Half Standard Dose

Experimental group will be treated for full upper face wrinkles with half of the standard recommended doing of onabotulinumtoxinA

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER

NCT04994990 - Effective OnabotulinumtoxinA Dose Response Study for Upper Facial Wrinkles | Biotech Hunter | Biotech Hunter